Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7542348

Concept 2023-06-01 to
2023-08-31
2022-06-01 to
2022-08-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,080,000,000 JPY
1,501,000,000 JPY
Non-operating income
Non-operating income
42,000,000 JPY
36,000,000 JPY
Non-operating expenses
Non-operating expenses
30,000,000 JPY
62,000,000 JPY
Ordinary profit (loss)
1,092,000,000 JPY
1,475,000,000 JPY
Extraordinary losses
Extraordinary losses
0 JPY
4,000,000 JPY
Profit (loss) before income taxes
1,092,000,000 JPY
1,470,000,000 JPY
Profit (loss)
663,000,000 JPY
926,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.